186 related items for PubMed ID: 7888291
1. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.
Grove A, Allam C, McFarlane LC, McPhate G, Jackson CM, Lipworth BJ.
Br J Clin Pharmacol; 1994 Dec; 38(6):527-32. PubMed ID: 7888291
[Abstract] [Full Text] [Related]
2. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ, Clark RA, Lipworth BJ.
Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
[Abstract] [Full Text] [Related]
3. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ, Grove A, Cargill RI, Lipworth BJ.
Thorax; 1996 Mar; 51(3):262-6. PubMed ID: 8779128
[Abstract] [Full Text] [Related]
4. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
Agertoft L, Pedersen S.
Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
[Abstract] [Full Text] [Related]
5. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Jul; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
6. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.
Grahnén A, Eckernäs SA, Brundin RM, Ling-Andersson A.
Br J Clin Pharmacol; 1994 Dec; 38(6):521-5. PubMed ID: 7888290
[Abstract] [Full Text] [Related]
7. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ, Lipworth BJ.
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[Abstract] [Full Text] [Related]
8. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ, Clark DJ, McFarlane LC.
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[Abstract] [Full Text] [Related]
9. Effects of short-term exposure to high-dose inhaled corticosteroids on novel markers of bone metabolism.
Grove A, McFarlane LC, Jackson CM, Lipworth BJ.
Eur J Clin Pharmacol; 1996 Aug; 50(4):275-7. PubMed ID: 8803518
[Abstract] [Full Text] [Related]
10. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
11. Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers.
Wilson AM, Clark DJ, McFarlane L, Lipworth BJ.
Eur J Clin Pharmacol; 1997 Mar; 53(1):33-7. PubMed ID: 9349927
[Abstract] [Full Text] [Related]
12. Assessment of the relative systemic potency of inhaled fluticasone and budesonide.
Boorsma M, Andersson N, Larsson P, Ullman A.
Eur Respir J; 1996 Jul; 9(7):1427-32. PubMed ID: 8836654
[Abstract] [Full Text] [Related]
13. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
Agertoft L, Pedersen S.
J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
[Abstract] [Full Text] [Related]
14. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
[Abstract] [Full Text] [Related]
15. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[Abstract] [Full Text] [Related]
16. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers.
Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR.
Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140
[Abstract] [Full Text] [Related]
17. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers.
Lönnebo A, Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Eckernäs SA.
Eur J Clin Pharmacol; 1996 May; 49(6):459-63. PubMed ID: 8706770
[Abstract] [Full Text] [Related]
18. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[Abstract] [Full Text] [Related]
19. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
Selroos O, Halme M.
Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636
[Abstract] [Full Text] [Related]
20. Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.
Harmanci E, Colak O, Metintas M, Alatas O, Yurdasiper A.
Allergol Immunopathol (Madr); 2001 Dec; 29(1):22-7. PubMed ID: 11449531
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
